Dickson M A, Hahn W C, Ino Y, Ronfard V, Wu J Y, Weinberg R A, Louis D N, Li F P, Rheinwald J G
Division of Dermatology, Department of Medicine and Harvard Skin Disease Research Center, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Mol Cell Biol. 2000 Feb;20(4):1436-47. doi: 10.1128/MCB.20.4.1436-1447.2000.
Normal human cells exhibit a limited replicative life span in culture, eventually arresting growth by a process termed senescence. Progressive telomere shortening appears to trigger senescence in normal human fibroblasts and retinal pigment epithelial cells, as ectopic expression of the telomerase catalytic subunit, hTERT, immortalizes these cell types directly. Telomerase expression alone is insufficient to enable certain other cell types to evade senescence, however. Such cells, including keratinocytes and mammary epithelial cells, appear to require loss of the pRB/p16(INK4a) cell cycle control mechanism in addition to hTERT expression to achieve immortality. To investigate the relationships among telomerase activity, cell cycle control, senescence, and differentiation, we expressed hTERT in two epithelial cell types, keratinocytes and mesothelial cells, and determined the effect on proliferation potential and on the function of cell-type-specific growth control and differentiation systems. Ectopic hTERT expression immortalized normal mesothelial cells and a premalignant, p16(INK4a)-negative keratinocyte line. In contrast, when four keratinocyte strains cultured from normal tissue were transduced to express hTERT, they were incompletely rescued from senescence. After reaching the population doubling limit of their parent cell strains, hTERT(+) keratinocytes entered a slow growth phase of indefinite length, from which rare, rapidly dividing immortal cells emerged. These immortal cell lines frequently had sustained deletions of the CDK2NA/INK4A locus or otherwise were deficient in p16(INK4a) expression. They nevertheless typically retained other keratinocyte growth controls and differentiated normally in culture and in xenografts. Thus, keratinocyte replicative potential is limited by a p16(INK4a)-dependent mechanism, the activation of which can occur independent of telomere length. Abrogation of this mechanism together with telomerase expression immortalizes keratinocytes without affecting other major growth control or differentiation systems.
正常人类细胞在培养中表现出有限的复制寿命,最终通过一种称为衰老的过程停止生长。渐进性端粒缩短似乎触发了正常人成纤维细胞和视网膜色素上皮细胞的衰老,因为端粒酶催化亚基hTERT的异位表达可直接使这些细胞类型永生化。然而,仅端粒酶表达不足以使某些其他细胞类型逃避衰老。这些细胞,包括角质形成细胞和乳腺上皮细胞,除了hTERT表达外,似乎还需要丧失pRB/p16(INK4a)细胞周期控制机制才能实现永生化。为了研究端粒酶活性、细胞周期控制、衰老和分化之间的关系,我们在两种上皮细胞类型,即角质形成细胞和间皮细胞中表达了hTERT,并确定了其对增殖潜能以及细胞类型特异性生长控制和分化系统功能的影响。异位hTERT表达使正常间皮细胞和一种癌前p16(INK4a)阴性角质形成细胞系永生化。相比之下,当从正常组织培养的四种角质形成细胞株被转导以表达hTERT时,它们并未完全从衰老中挽救出来。在达到其亲代细胞株的群体倍增极限后,hTERT(+)角质形成细胞进入了一个长度不确定且缓慢的生长阶段,从中出现了罕见的、快速分裂的永生化细胞。这些永生化细胞系经常持续缺失CDK2NA/INK4A基因座,或者在其他方面p16(INK4a)表达不足。然而,它们通常保留了其他角质形成细胞生长控制,并在培养和异种移植中正常分化。因此,角质形成细胞的复制潜能受到一种依赖p16(INK4a)的机制的限制,该机制的激活可以独立于端粒长度而发生。废除这种机制并结合端粒酶表达可使角质形成细胞永生化,而不影响其他主要的生长控制或分化系统。